Dr. Lim is a Consultant Neurologist and Professor at the University of Malaya, Kuala Lumpur, where he runs a very busy government clinic and private practice seeing many patients with Parkinson’s disease (PD) and other Movement Disorders, including complicated cases requiring advanced treatments such as deep brain stimulation. Dr. Lim earned his medical and research doctorate degrees from the University of Melbourne and was admitted to Fellowship of the Royal Australasian College of Physicians after completing advanced training in adult Internal Medicine and Neurology in Melbourne. Dr. Lim trained in general neurology and subspecialized in Parkinson’s & Movement Disorders, at world-renowned centres in Melbourne and Toronto (the latter supported by the Edmond J. Safra Fellowship, under Prof. Anthony Lang). He has published widely in the field of Movement Disorders (Parkinson's as well as a variety of rarer movement disorders), with ~200 peer-reviewed journal papers and book chapters, including first-author publications in Lancet Neurology, Archives of Neurology/JAMA Neurology, Movement Disorders, etc. and co-authorship in journals such as Nature Genetics, Nature Reviews Neurology, Annals of Neurology, and Brain (12K citations, h-index 48). He is an Associate Editor for Nature Partner Journal (npj) Parkinson's Disease and Neurology Asia (for several years previously also for Science Advances), and Guest Editor for the Journal of Parkinson's Disease, and is on several Editorial Boards including Parkinsonism & Related Disorders and Neurotorium. Dr. Lim is immediate Past-Chair of the Asian-Oceanian section of the International Parkinson & Movement Disorder Society (MDS) (which has ~3.5K members, from the Clinical and Basic science communities), and serves on several MDS Committees/Task Forces (International Executive Committee [IEC], Evidence-Based Medicine [EBM]; Movement Disorders in Asia; etc.). He is a Steering Committee member, and Co-Lead of the Under-Represented Populations Working Group, of the Global Parkinson's Genetics Program (GP2). He is a holder and/or Reviewer of grants for PD-related funding organisations such as the Michael J. Fox Foundation (MJFF), and the United Kingdom's National Institute for Health and Care Research (NIHR) and Cure Parkinspn's Trust (CPT). With a strong commitment to teaching/training, Dr. Lim has organized numerous teaching courses on Parkinson’s & Movement Disorders, and delivered and/or participated in hundreds of international-level lectures and expert panels throughout Asia-Oceania, North America, and Europe. These have often been under the auspices of the MDS, as MDS Visiting Professor, MDS Ambassador, or MDS Virtual Professor. As a versatile speaker with broad-ranging expertise, he has been invited to give numerous Plenary Lectures, including at the flagship MDS Annual Congress (Toronto 2011, Dublin 2012, Nice 2019, Philadelphia/Virtual 2020, Copenhagen 2023, Honolulu 2025) and at the World Parkinson's Congress (Kyoto 2019). In 2025, together with Profs. Nobutaka Hattori and Pramod Pal, he Chaired a highly successful 9th Asian & Oceanian Parkinson's & Movement Disorders Congress (AOPMC) in Tokyo. He has provided movement disorder fellowship/observership training to neurologists from multiple underserved countries, including Indonesia, Myanmar, Bangladesh, Kyrgyzstan, Uzbekistan, Pakistan, India, the Philippines, and Nigeria, often under the auspices of the MDS (Visiting Trainee Grants or Centre-to-Centre Programs). Dr. Lim is a Medical Advisor to the Malaysian Parkinson’s Disease Association, and a founding member (and Immediate-Past Chair) of the Malaysian Movement Disorder Council. He was elected as a Fellow of the Malaysian Academy of Sciences in 2017. In recognition of his leadership in the Movement Disorders field, he was invited to be an Expert Panelist/Consultant to the World Health Organization (WHO) in 2020 to address global policy, implementation and research related to PD. Dr. Lim's research interests are multi-dimensional, with a focus on the following areas: (i) PD (particularly genetics/genetic epidemiology/genotype-phenotype correlations; evidence-based medicine/clinical trials; non-motor features including gastrointestinal aspects; comorbidities; patient-centred care; and rating scales/disease staging); (ii) Parkinson-plus syndromes and other miscellaneous/"orphan" movement disorders, including progressive supranuclear palsy (PSP).

Dr. Mohd Fairuz Zamani, commonly known as Fairuz Zamani, is currently serving as an academic at the Faculty of Creative Arts, Universiti Malaya (UM), where he holds the position of Deputy Dean of Postgraduate, Research & Innovation. His research focuses on contemporary Malaysian music composition, with particular interest in developing analytical frameworks for the works of Malaysian composers. Dr. Fairuz has published in several esteemed academic journals, including Muzikološki Zbornik, Malaysian Journal of Music, Harmonia: Journal of Arts Research and Education, Wacana Seni, and 3L: Language, Linguistics, Literature. His forthcoming articles are scheduled for publication in Wacana Seni (late 2025) and Resonancias (mid 2026). He has led research projects aimed at promoting Malaysian piano repertoire to wider audiences and currently oversees a grant focused on analytical methodologies for selected works by Razak Abdul Aziz. Beyond academia, Dr. Fairuz is an active composer. He has been a member of the Malaysian Composers Collective since 2022, under which he premiered Phrygian Fantasy (2023), Kenyalang Rhapsody (2022), and Two Miniatures (2022). During his tenure as resident arranger for Koir Kebangsaan Malaysia and Permata Seni Koir, he composed two commissioned works for the Department of Culture and Arts, Ministry of Tourism, Arts and Culture (MOTAC): Nuance of Rebab Fantasy (2013) and Mek Mulung Cycle (2018). His choral arrangements continue to be performed in national and international competitions, often by award-winning ensembles. Dr. Fairuz is also a seasoned performer and adjudicator. In June 2025, he was awarded the Prix de Perfectionnement à l’unanimité for outstanding performance at the Conservatoire International de Musique de Paris. His recent notable performances include Music of Johan Othman and Razak Aziz (2023), The Carnival of the Animals (2022) with the National Symphony Orchestra of Malaysia, and Beethoven’s 250th Birthday Celebration Concert at the German Embassy in Kuala Lumpur (2021). He has also served as adjudicator for events such as the MAME Folksong Festival (Piano category) and the 2nd China-ASEAN Music and Arts Cultural Exchange in 2024.

Dr Mohd Shahnaz Hasan is a Consultant Anaesthesiologist and Critical Care Physician at Universiti Malaya Medical Centre and an Assoc Professor at the Department of Anaesthesiology, Faculty of Medicine, Universiti Malaya. He received his MBBS and postgraduate degree in Anaesthesiology from Universiti Malaya and went on to complete his Fellowship in Emergency & Critical Care Ultrasound. Majority of his time is devoted to clinical work, teaching and research. Over the past 10 years, he has maintained active collaborations with international research institutions and researchers, conducting research in areas related to critical care nutrition, nephrology, mechanical ventilation, sedation, and antimicrobials in critically ill patients. He is currently the PI of the following ongoing international clinical trials and research projects: MEGAROX (MRINZ), SPICE IV (Monash), VICTORY trial (Wurzburg), EFFORT-X(Queens), EQUIP-ICU (Oxford), REMAP-CAP (Monash) and FOIL-INFLAME (Malaysia). He is also the institutional lead in the CCAA project (Collaboration for Research, Implementation & Training in Intensive Care in Asia and Africa) which is supported by the Wellcome Trust. His past and ongoing work with the University of Queensland team in antimicrobial pharmacokinetics and optimisation of antibiotic dosing/delivery includes: BLISS, SAFE-ICU, DECISIVE, BLING III & PK/PD, PNEUDOS, and COLLABORATE. Apart from his significant contribution in the research and care of critically ill patients, he is also heavily involved in the provision of perioperative anaesthesia care for major complex spinal surgery, which include more than 2000 cases of complex congenital, neuromuscular and idiopathic scoliosis deformity surgery in young children and adolescents. Dr Shahnaz has received local and international research grants worth more than MYR 2.27 mil. He has more than 100 publications in high impact journals (WOS) with a H-index of 16 and 2200 total citations, of which 20 as first, senior, or corresponding author. About 43% of the co-authored publications are from international collaboration with researchers in other countries or region and 37% of the publications are in the top 25% most cited worldwide.